Clinical Utility Study for Exo-PDAC
Pancreas Cancer
About this trial
This is an interventional diagnostic trial for Pancreas Cancer
Eligibility Criteria
Inclusion Criteria: Board-certified for at least two years Averaging at least 20 hours per week of clinical and patient care duties over the last six months Routinely evaluate patients at risk for pancreatic cancer in their practice Practicing in the U.S. English speaking Access to the internet Informed, signed, and voluntarily consented to be in the study Exclusion Criteria: Non-English speaking Unable to access the internet Not practicing in the U.S. Not averaging at least 20 hours per week of clinical or patient care duties over the last six months Previous exposure to the test Do not voluntarily consent to be in the study
Sites / Locations
- QURE Healthcare
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
Experimental
Standard Practice
Intervention Group 1 - Test Results Given
Intervention Group 2 - Test Results Optional
The control group treats their simulated patients using standard practice and has no introduction to the new diagnostic test.
Intervention Group 1 will receive information regarding the test and will be given the test results, whether selected or not, in Round 2 of CPV administration.
Intervention Group 2 will receive information regarding the test and will be given the test results if selected in Round 2 of CPV administration.